Therapy Areas: AIDS & HIV
Moderna signs COVID-19 vaccine supply agreements for Taiwan and Colombia
10 February 2021 -

Biotechnology company Moderna Inc (Nasdaq:MRNA) reported on Tuesday the receipt of supply agreements for the delivery of COVID-19 Vaccine Moderna to the government of Taiwan and Colombia, respectively, in mid-2021.

Under the terms of the agreements, the company will supply five million doses to Taiwan and 10 million doses to Colombia, respectively.

Though the COVID-19 Vaccine Moderna is not currently approved for use in Taiwan or Colombia, the company will work with regulators to pursue necessary approvals prior to distribution.

The COVID-19 Vaccine Moderna is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from the National Institute of Allergy and Infectious Disease's (NIAID) Vaccine Research Center.

Login
Username:

Password: